" Synbio Technologies was decided as one of the Top 10 companies in 2020 that provide drug discovery and development services. "
-- Pharma Tech Outlook Magazine
Founded in 2013 by a group of passionate synthetic biologists with decades of industry experience and a proven track record of delivering cost-effective DNA solutions, Synbio Technologies is incorporated with a single mission in mind to empower scientific discoveries and drug innovation by providing the most advanced and cost-effective DNA technology platform. The company has developed a full range of DNA reading (sequencing), DNA writing (synthesis) and DNA editing (engineering) capabilities and delivered satisfactory solutions to global researchers for various applications, including diagnostic DNA probes, precision medicine, protein production, antibody discovery, vaccine development, novel enzymes, molecular breeding and biofuel implication etc. The company has over 250 scientific staff and its state of the art production facility is certified with the highest DNA manufacturing standards (ISO9001 & ISO13485).